Further studies are required to explain whether the observed anti-inflammatory effect of NAC supplementation is associated with NAC-induced inhibition of proteasome activity followed by the downregulation of NF-κB activity, or whether this effect could be secondary to the systemic influence of NAC (preventing insulin resistance). The gene discussed is NFKB1; the disease is Insulin resistance.